NCT02270788 Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02261480 A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease Status COMPLETED Phase N/A
NCT02259348 Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation Status TERMINATED Phase PHASE2
NCT02256137 A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02241005 Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci Status COMPLETED Phase NA
NCT02227472 Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease Status COMPLETED Phase N/A
NCT02212561 Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT02206906 Incentives to Promote Medication Adherence Among HIV-Infected Youth Status COMPLETED Phase N/A
NCT02199041 Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen Status TERMINATED Phase PHASE2
NCT02193724 Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma Status COMPLETED Phase N/A
NCT02159443 Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody Status COMPLETED Phase N/A
NCT02130869 A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT02125786 A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02114229 Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2